Holen Sie sich die Stockscreener-App
56.45
0.47%
-0.38
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CVS?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$56.83
Offen:
$56.8
24-Stunden-Volumen:
617.84K
Relative Volume:
0.06
Marktkapitalisierung:
$71.44B
Einnahmen:
$368.91B
Nettoeinkommen (Verlust:
$5.02B
KGV:
8.5143
EPS:
6.63
Netto-Cashflow:
$1.69B
1W Leistung:
+2.68%
1M Leistung:
-2.76%
6M Leistung:
-1.32%
1J Leistung:
-16.91%
1-Tages-Spanne:
$56.41
$56.93
1-Wochen-Bereich:
$52.71
$57.67
52-Wochen-Spanne:
$52.71
$83.25
Cvs Health Corp Stock (CVS) Company Profile
Firmenname
Cvs Health Corp
Sektor
Branche
Telefon
(401) 765-1500
Adresse
ONE CVS DR., WOONSOCKET
Vergleichen Sie CVS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| CVS | 56.47 | 71.44B | 368.91B | 5.02B | 1.69B | 6.63 |
| UNH | 600.15 | 543.90B | 389.07B | 14.32B | 13.10B | 23.04 |
| ELV | 398.11 | 91.77B | 174.02B | 6.42B | 871.00M | 25.47 |
| CI | 323.08 | 89.04B | 229.75B | 3.04B | 5.18B | 17.73 |
| HUM | 294.50 | 34.80B | 115.01B | 1.36B | -4.34B | 24.12 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-10 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
| 2024-05-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-05-02 | Herabstufung | UBS | Buy → Neutral |
| 2024-05-01 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-22 | Eingeleitet | HSBC Securities | Buy |
| 2023-09-19 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Herabstufung | Edward Jones | Buy → Hold |
| 2023-05-26 | Eingeleitet | Piper Sandler | Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Eingeleitet | Goldman | Buy |
| 2021-12-01 | Eingeleitet | Seaport Research Partners | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-03-17 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-01-08 | Hochstufung | Jefferies | Hold → Buy |
| 2020-09-17 | Eingeleitet | Piper Sandler | Overweight |
| 2020-07-01 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-05-14 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-06-05 | Hochstufung | Standpoint Research | Hold → Buy |
| 2019-04-29 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Eingeleitet | Guggenheim | Buy |
| 2019-04-15 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Bestätigt | BofA/Merrill | Buy |
| 2019-03-13 | Eingeleitet | Bernstein | Outperform |
| 2019-02-20 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2018-12-18 | Eingeleitet | Barclays | Overweight |
| 2018-11-29 | Fortgesetzt | Goldman | Neutral |
| 2018-11-28 | Eingeleitet | Evercore ISI | Outperform |
| 2018-10-26 | Fortgesetzt | Wolfe Research | Peer Perform |
| 2018-07-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-02-13 | Bestätigt | Citigroup | Neutral |
Alle ansehen
Cvs Health Corp Aktie (CVS) Neueste Nachrichten
Landscape Capital Management L.L.C. Buys 23,594 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health Co. (NYSE:CVS) Stock Position Decreased by Primecap Management Co. CA - MarketBeat
Payden & Rygel Purchases New Shares in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health Co. (NYSE:CVS) Shares Purchased by Advisors Asset Management Inc. - MarketBeat
PNC Financial Services Group Inc. Has $46.82 Million Stake in CVS Health Co. (NYSE:CVS) - MarketBeat
61,838 Shares in CVS Health Co. (NYSE:CVS) Acquired by B. Metzler seel. Sohn & Co. Holding AG - MarketBeat
CVS Can't Dodge Proposed Action Over 'Non-Drowsy' Claims - Law360
CVS Health Corp. stock outperforms competitors on strong trading day - MarketWatch
CVS Hit With California Class Action After Minute Clinic Layoffs - Bloomberg Law
Big Pharma's Pharmacy-Benefit Managers Accuse FTC of Overreach In Effort to Reshape Drug Rebate System - Benzinga
Payer Roundup—CVS insider trading scandal; DOJ examining PBMs - Fierce healthcare
CVS Health bulks its board up to 16 members, adds hedge fund CEO - MSN
New York targets PBMs with new transparency, competition rules - Modern Healthcare
Is CVS Health Stock an Underrated Buy? - Yahoo! Voices
New CEO at CVS begins to build his team with a goal of reviving the struggling health care giant - MSN
How GC-of-Year Sam Khichi Has Helped CVS Barrel Through Challenges - Law.com
New York State Aims to Rein In Pharmacy Plans With New Rules - Bloomberg
Leerink Partnrs Has Positive View of CVS Health Q2 Earnings - MarketBeat
CVS Health Co. (NYSE:CVS) Shares Bought by Meeder Asset Management Inc. - MarketBeat
Bear of the Day: CVS Health (CVS) - Yahoo Finance
MAI Capital Management Trims Stock Position in CVS Health Co. (NYSE:CVS) - MarketBeat
Oak Street Co-Founder Exiting CVS - Healthcare Innovation
CVS Health Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
CVS added Glenview’s Robbins to board under activist pressure - The Boston Globe
CVS makes deal with Glenview Capital, adds four board seats - Yahoo Finance
CVS continues executive leadership shakeup - The Business Journals
CVS, Cigna, UnitedHealth Sue to Nix FTC Case on Insulin Cost (1) - Bloomberg Law
Aetna Better Health of Illinois introduces same-day pharmacy delivery to members - Drug Store News
Leerink Partnrs Reduces Earnings Estimates for CVS Health - MarketBeat
Wells Fargo upgrades CVS Health to Overweight, ups price target to $66 - Yahoo Finance
Quest Partners LLC Invests $1.83 Million in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS adds four new board members in deal with Glenview as CEO pursues a turnaround - Blue Water Healthy Living
Wachtell-Led CVS Adds Glenview CEO, Others To Board - Law360
Activist shareholder Glenview gains CVS board seat - The Business Journals
CVS Health Stock Is Moving Higher Monday: What's Going On? - Benzinga
Bear Of The Day: CVS Health (CVS) - Barchart
CVS Expands Board Amid Investor Pressure, Adds Glenview CEO and Industry Experts - Yahoo Finance
CVS Health names four new board members in deal with activist investor Glenview Capital - Yahoo! Voices
CVS Adds Glenview’s Robbins to Board Under Activist Pressure - Yahoo Finance
CVS Adds Glenview’s Robbins to Board Under Activist Pressure (2) - Bloomberg Law
CVS Health adds 4 board members from hedge fund - Providence Business News
CVS Health Adds Four New Board Members - Inkl
Activist investor Glenview secures 4 board seats at CVS Health - Financial Times
CVS adds four new board members in deal with Glenview Capital - MSN
CVS adds Glenview Capital Management founder to board - Modern Healthcare
CVS adds four new board members in deal with Glenview as CEO pursues a turnaround By Reuters - Investing.com
CVS Health (NYSE:CVS) Upgraded by Wells Fargo & Company to "Overweight" Rating - MarketBeat
CVS strikes deal with activist Glenview Capital for four board seats - CNBC
CVS Health Corporation (CVS) Expands Board and Enhances Leadersh - GuruFocus.com
CVS Health gains as board grows on deal with activist investor Glenview - Proactive Investors UK
Short Interest in CVS Health Co. (NYSE:CVS) Increases By 5.0% - MarketBeat
Finanzdaten der Cvs Health Corp-Aktie (CVS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):